Cargando…
SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity
SOT101 is a superagonist fusion protein of interleukin (IL)-15 and the IL-15 receptor α (IL-15Rα) sushi+ domain, representing a promising clinical candidate for the treatment of cancer. SOT101 among other immune cells specifically stimulates natural killer (NK) cells and memory CD8(+) T cells with n...
Autores principales: | Antosova, Zuzana, Podzimkova, Nada, Tomala, Jakub, Augustynkova, Katerina, Sajnerova, Katerina, Nedvedova, Eva, Sirova, Milada, de Martynoff, Guy, Bechard, David, Moebius, Ulrich, Kovar, Marek, Spisek, Radek, Adkins, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590108/ https://www.ncbi.nlm.nih.gov/pubmed/36300122 http://dx.doi.org/10.3389/fimmu.2022.989895 |
Ejemplares similares
-
Radiotherapy in Combination With Cytokine Treatment
por: Palata, Ondrej, et al.
Publicado: (2019) -
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
por: Rakova, Jana, et al.
Publicado: (2021) -
COVID-19 in SOT versus non-SOT
por: Allam, Sridhar R., et al.
Publicado: (2021) -
TXG at SOT.
por: Potera, Carol
Publicado: (2003) -
Rio Sot /
por: Leonov, Leonid, 1899-1994
Publicado: (1981)